NEW YORK (AP) ” Valeant is selling three skincare brands to L’Oral for $1.3 billion. Shares of the pharmaceutical company, down 80 percent in the past year, soared more than 13 percent before the opening bell Tuesday. Valeant Pharmaceuticals International Inc. said that the sale’s proceeds will be used to pay down debt.
